Add to ORKGTranscranial sonothrombolysis using high-intensity focused ultrasound: impact of increasing output power on clot fragmentatio
It is estimated that only 2-6% of patients receive thrombolytic therapy for acute ischemic stroke su...
Tissue plasminogen activator (tPA) remains the only drug for recanalization in acute ischemic stroke...
Purpose: To review all available literature on catheter-directed ultrasound-accelerated thrombolysis...
Abstract Background The primary goal of this study was to investigate the relationship between incre...
The primary method for treating acute ischemic stroke - the administration of thrombolytics - is ass...
Background The limited efficacy of thrombolytic therapy in patients with ischemic stroke has created...
Abstract The goal was to test the effects of various combinations of pulse widths (PW) and duty cycl...
The low and incomplete recanalization performance of thrombolytic therapy in patients with acute isc...
The vascular occlusion by the thrombi is the main reason for ischemic stroke and deep vein thrombosi...
In this thesis focused ultrasound thrombolysis was investigated in vitro and in vivo. At high intens...
Objective High Intensity Focused Ultrasounds (HIFU) demonstrated the ability to destroy bl...
Abstract—Poor recovery after systemic tissue plasminogen activator (tPA) therapy could result from t...
SummaryIntravenous tissue plasminogen activator (tPA) remains the only approved, fastest and widely ...
Background. Tissue plasminogen activator (TPA) activity may be enhanced with ultrasound, potentially...
Transcranial focused ultrasound is a rapidly-advancing therapeutic modality. In recent years, clinic...
It is estimated that only 2-6% of patients receive thrombolytic therapy for acute ischemic stroke su...
Tissue plasminogen activator (tPA) remains the only drug for recanalization in acute ischemic stroke...
Purpose: To review all available literature on catheter-directed ultrasound-accelerated thrombolysis...
Abstract Background The primary goal of this study was to investigate the relationship between incre...
The primary method for treating acute ischemic stroke - the administration of thrombolytics - is ass...
Background The limited efficacy of thrombolytic therapy in patients with ischemic stroke has created...
Abstract The goal was to test the effects of various combinations of pulse widths (PW) and duty cycl...
The low and incomplete recanalization performance of thrombolytic therapy in patients with acute isc...
The vascular occlusion by the thrombi is the main reason for ischemic stroke and deep vein thrombosi...
In this thesis focused ultrasound thrombolysis was investigated in vitro and in vivo. At high intens...
Objective High Intensity Focused Ultrasounds (HIFU) demonstrated the ability to destroy bl...
Abstract—Poor recovery after systemic tissue plasminogen activator (tPA) therapy could result from t...
SummaryIntravenous tissue plasminogen activator (tPA) remains the only approved, fastest and widely ...
Background. Tissue plasminogen activator (TPA) activity may be enhanced with ultrasound, potentially...
Transcranial focused ultrasound is a rapidly-advancing therapeutic modality. In recent years, clinic...
It is estimated that only 2-6% of patients receive thrombolytic therapy for acute ischemic stroke su...
Tissue plasminogen activator (tPA) remains the only drug for recanalization in acute ischemic stroke...
Purpose: To review all available literature on catheter-directed ultrasound-accelerated thrombolysis...